Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome

Journal of General Virology

Volumn 80, Issue 2, 1999, Pages 399-408

  De Gruijl, Tanja D ^a   Bontkes, Hetty J ^a   Walboomers, Jan M M ^a   Coursaget, Pierre ^b   Stukart, Marij J ^a   Dupuy, Catherine ^b   Kueter, Esther ^a   Verheijen, René H M ^a   Helmerhorst, Theo J M ^a,d   Duggan Keen, Margaret F ^c   Stern, Peter L ^c   Meijer, Chris J L M ^a   Scheper, Rik J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITÉ DE TOURS   (France)

^c CHRISTIE HOSPITAL   (United Kingdom)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; EPITOPE; HLA DQ ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN G; INTERLEUKIN 2; VIRUS ANTIBODY;

ADULT; ANTIBODY RESPONSE; ARTICLE; COHORT ANALYSIS; FEMALE; HELPER CELL; HUMAN; IMMUNE RESPONSE; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; UTERINE CERVIX CARCINOMA IN SITU; VIRUS IMMUNITY; WART VIRUS;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; MIRIDAE; PAPOVAVIRIDAE;

EID: 0033047275     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-80-2-399     Document Type: Article

References (33)

1. Bontkes, H. J., de Gruijl, T. D., Walboomers, J. M. M., Schiller, J. T., Dillner, J., Helmerhorst, T. J. M., Verheijen, R. H. M., Scheper, R. J. & Meijer, C. J. L. M. (1999). Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16. Journal of General Virology 80, 409-417.
2. Borysiewicz, L. K., Fiander, A., Nimako, M., Man, S., Wilkinson, G. W. G., Westmoreland, D., Evans, A. S., Adams, M., Stacey, S. N., Boursnell, M. E. G., Rutherford, E., Hickling, J. K. & Inglis, S. C. (1996). A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer. Lancet 347, 1523-1527.
3. Breitburd, F., Kirnbauer, R., Hubbert, N. L., Nonnenmacher, B., Trin-Dinh-Desmarquet, C., Orth, C., Schiller, J. T. & Lowy, D. R. (1995). Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. Journal of Virology 69, 3959-3963.
4. Carter, J. J., Koutsky, L. A., Wipf, G. C., Christensen, N. D., Lee, S.-K., Kuypers, J., Kiviat, N. & Galloway, D. A. (1996). The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women. Journal of Infections Diseases 174, 927-936.
5. Chaturvedi, P., Yu, Q., Southwood, S., Sette, A. & Singh, B. (1995). Peptide analogs with different affinities for MHC alter the cytokine profile of helper T cells. International Immunology 8, 745-755.
6. Chua, K. L., Wiklund, L., Lenner, P., Angstrom, T., Hallmans, G., Bergman, F., Sapp, M., Schiller, J., Wadell, G., Hjerpe, A. & Dillner, J. (1996). A prospective study on the risk of cervical intra-epithelial neoplasia among healthy subjects with serum antibodies to HPV compared with HPV DNA in cervical smears. International Journal of Cancer 68, 54-59.
7. de Gruijl, T. D., Bontkes, H. J., Stukart, M. J., Walboomers, J. M. M., Remmink, A. J., Verheijen, R. H. M., Helmerhorst, T. J. M., Meijer, C. J. L. M. & Scheper, R. J. (1996). T cell proliferative responses against human papillomavirus type 16 E7 oncoprotein are most prominent in cervical intraepithelial neoplasia patients with a persistent viral infection. Journal of General Virology 77, 2183-2191.
8. de Gruijl, T. D., Bontkes, H. J., Walboomers, J. M. M., Schiller, J. T., Stukart, M. J., Groot, B. S., Chabaud, M. M. R., Remmink, A. J., Verheijen, R. H. M., Helmerhorst, Th. J. M., Meijer, C. J. L. M. & Scheper, R. J. (1997). Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia. Journal of the National Cancer Institute 89, 630-638.
9. de Gruijl, T. D., Bontkes, H. J., Walboomers, J. M. M., Stukart, M. J., Doekhie, F. S., Remmink, A. J., Helmerhorst, Th. J. M., Verheijen, R. H. M., Duggan-Keen, M. F., Stern, P. L., Meijer, C. J. L. M. & Scheper, R. J. (1998). Differential T helper cell responses to human papillomavirus type 16 E7 related to viral clearance or persistence in patients with cervical neoplasia: a longitudinal study. Cancer Research 58, 1700-1706.
10. de Roda Husman, A. M., Walboomers, J. M. M., Meijer, C. J. L. M., Risse, E. K. J., Schipper, M. E. I., Helmerhorst, T. J. M., Bleker, O. P., Delius, H., van den Brule, A. J. C. & Snijders, P. J. F. (1994). Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes, using polymerase chain reaction. International Journal of Cancer 56, 802-806.
11. de Roda Husman, A.-M., Walboomers, J. M. M., van den Brule, A. J. C., Meijer, C. J. L. M. & Snijders, P. J. F. (1995). The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. Journal of General Virology 76, 1057-1062.
12. Duggan-Keen, M. F., Keating, P. J., Stevens, F. R. A., Sinnott, P., Snijders, P. J. F., Walboomers, J. M. M., Davidson, S., Hunter, R. D., Dyer, P. A. & Stern, P. L. (1996). Immunogenetic factors in HPV-associated cervical cancer: influence on disease progression. European Journal of Immunogenetics 23, 275-284.
13. Dupuy, C., Buzoni-Gatel, D., Touze, A., Le Cann, P., Bout, D. & Coursaget, P. (1997). Cell mediated immunity induced in mice by HPV-16 L1 virus-like particles. Microbial Pathogenesis 22, 219-225.
14. Ertl, H. C. J., Dietzschold, B., Gore, M., Otvos, L., Larson, J. K., Wunner, W. H. & Koprowski, H. (1989). Induction of rabies virus-specific T-helper cells by synthetic peptides that carry dominant T-helper cell epitopes of the viral ribonucleoprotein. Journal of Virology 63, 2885-2892.
15. Frazer, I. H. (1996). Immunology of papillomavirus infection. Current Opinions in Immunology 8, 484-491.
16. Höpfl, R., Sandbichler, M., Sepp, N., Heim, K., Müller-Holzner, E., Wartusch, B., Dapunt, O., Jochmus-Kudielka, I., ter Meulen, J., Gissmann, L. & Fritsch, P. (1991). Skin test for HPV type 16 proteins in cervical intraepithelial neoplasia. Lancet i, 373-374.
17. IARC (1995). Monographs on the Evaluation of the Carcinogenic Risks to Humans, vol. 64, The Human Papillomavirus, Lyon: International Agency for Research on Cancer.
18. Jacobs, M. V., de Roda Husman, A. M., van den Brule, A. J. C., Snijders, P. J. F., Meijer, C. J. L. M. & Walboomers, J. M. M. (1995). Group-specific differentiation between high- and low-risk human papillomavirus genotypes by using the general primer-mediated PCR and two cocktails of oligonucleotide probes. Journal of Clinical Microbiology 33, 901-905.
19. Kirnbauer, R., Taub, J., Greenstone, H., Roden, R., Dürst, M., Gissmann, L., Lowy, D. R. & Schiller, J. T. (1993). Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. Journal of Virology 67, 6929-6936.
20. Kirnbauer, R., Chandrachud, L M., O'Neil, B. W., Wagner, E. R., Grindlay, G. J., Armstrong, A., McGarvie, G. M., Schiller, J. T., Lowy, D. R. & Campo, M. S. (1996). Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization. Virology 219, 37-44.
21. Le Cann, P., Coursaget, P., Iochmann, S. & Touze, A. (1994). Self-assembly of human papillomavirus type 16 capsids by expression of the L1 protein in insect cells. FEMS Microbiology Letters 117, 269-274.
22. Lehtinen, M., Dillner, J., Knekt, P., Luostarinen, T., Aromaa, A., Kirnbauer, R., Koskela, P., Paavonen, J., Peto, R., Schiller, J. T. & Hakama, M. (1996). Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study. British Medical Journal 312, 537-539.
23. Luxton, J. C., Rose, R. C., Coletart, T., Wilson, P. & Shepherd, P. S. (1997). Serological and T-helper cell responses to human papillomavirus type 16 L1 in women with cervical dysplasia or cervical carcinoma and in healthy controls. Journal of General Virology 78, 917-923.
24. Nonnenmacher, B., Hubbert, N. L., Kirnbauer, R., Shah, K. V., Munoz, N., Bosch, F. X., Desanjose, S., Viscidi, R., Lowy, D. R. & Schiller, J. T. (1995). Serologic response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain. Journal of Infectious Diseases 172, 19-24.
25. Remmink, A. J., Walboomers, J. M. M., Helmerhorst, T. J. M., Voorhorst, F. J., Rozendaal, L., Risse, E. K. J., Meijer, C. J. L. M. & Kenemans, P. (1995). The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. International Journal of Cancer 61, 306-311.
26. Schiller, J. T. & Roden, R. B. S. (1995). Papillomavirus-like particles. Papillomavirus Report 6, 121-128.
27. Shepherd, P. S., Rowe, A. J., Cridland, J. C., Coletart, T., Wilson, P. & Luxton, J. C. (1997). Proliferative T cell responses to human papillomavirus type 16 L1 peptides in patients with cervical dysplasia. Journal of General Virology 77, 593-602.
28. Suzich, J. A., Ghim, S.-J., Palmer-Hill, F. J., White, W. I., Tamura, J. K., Bell, J. A., Newsome, J. A., Jenson, A. B. & Schlegel, R. (1995). Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proceedings of the National Academy of Sciences, USA 92, 11553-11557.
29. Tindle, R. W. (1996). Human papillomavirus vaccines for cervical cancer. Current Opinions in Immunology 8, 643-650.
30. Tsukui, T., Hildesheim, A., Schiffman, M. H., Luci, J., III, Contois, D., Lawler, P., Rush, B. B., Lorincz, A. T., Corrigan, A., Burk, R. D., Qu, W., Marshall, M. A., Mann, D., Carrington, M., Clerici, M., Shearer, G. M., Carbone, D. P., Scott, D. R., Houghten, R. A. & Berzofsky, J. A. (1996). Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology. Cancer Research 56, 3967-3974.
31. Wang, Z., Hansson, B. G., Forslund, O., Dillner, L., Sapp, M., Schiller, J. T., Bjerre, B. & Dillner, J. (1996). Cervical mucus antibodies against human papillomavirus type 16, 18, and 33 capsids in relation to presence of viral DNA. Journal of Clinical Microbiology 34, 3056-1062.
32. Wikström, A., van Doornum, G. J. J., Quint, W. G. V., Schiller, J. T. & Dillner, J. (1995). Identification of human papillomavirus sero-conversions. Journal of General Virology 76, 529-539.
33. Zinkernagel, R. M. (1996). Immunology taught by viruses. Science 271, 173-178.